Clinical trial
Effect of Haemodialysis on the Efficacy of Antiplatelet Agents
NCT03330223 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Haemodialysis on the Efficacy of Antiplatelet Agents
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 10, 2017
- Completion date
- September 1, 2019
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, hemolysis, renal failure